<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-83215</identifier>
<setSpec>1134-3230</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prevalence of autoimmune thyroid disease in patients with type 1 diabetes</dc:title>
<dc:description xml:lang="en">Objective: To evaluate the prevalence of autoimmune thyroid disease in type1 diabetes patients and their association to clinical and analytical parameters.Methodology: A retrospective observational study of type 1 diabetes patientswas designed to analyze the prevalence of autoimmune thyroid disease andrelated factors. Results: The study included 507 patients with type 1 diabetes(50.4% women), aged 33.5 ± 11.8 years with an average duration of diabetesof 16.1 ± 9.5 years. The average level of HbA1c was 7.8 ± 1.4%.Theprevalence of autoimmune thyroid function disorder was 17.8% (9.9% primaryhypothyroidism, 7.1% subclinical hypothyroidism, and 0.8% Graves disease).There was a positive association between thyroid disease and femalegender (24.6% versus 10.8% in men, p &lt;0.001), smoking (15.6% versus2.2%, p= 0.039) and serum LDL levels (110.1 ± 31.4 mg/dL versus 102.9± 28.8 mg/dL; p &lt;0.043). Conclusion: Prevalence of autoimmune thyroiddisease in type 1 diabetes patients is high and it is associated with femalegender, smoking and increased LDL levels. We suggest a systematic screeningfor autoimmune thyroid disease in type 1 diabetes to establish an early diagnoseand treatment(AU)</dc:description>
<dc:creator>Roca, M. M</dc:creator>
<dc:creator>Ortego, J</dc:creator>
<dc:creator>Baena, M. G</dc:creator>
<dc:creator>Aguilar-Diosdado, M</dc:creator>
<dc:creator>Carral, F</dc:creator>
<dc:creator>Cayón, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Evaluar la prevalencia de enfermedad tiroidea autoinmune (ETA) enpacientes con diabetes tipo 1 (DM1) y su relación con variables clínicas y analíticas.Material y métodos: Estudio observacional descriptivo en pacientescon DM1 en el que se analiza la prevalencia de ETA y los factores relacionados.Resultados: Se estudiaron 507 pacientes con DM1 (50,4% mujeres)de 33,5 ± 11,8 años de edad y 16,1 ± 9,5 años de evolución de la DM1, ycon un nivel medio de HbA1c del 7,8 ± 1,4%. El 17,8% de los pacientes presentabaETA (9,9% hipotiroidismo primario, 7,1% hipotiroidismo subclínico y0,8% enfermedad de Graves). Los pacientes DM1 y ETA eran, con mayor frecuencia,mujeres (24,6 frente a 10,8%; p &lt;0,001) y fumadores (15,6 frentea 2,2%; p= 0,039) y presentaban niveles séricos de colesterol LDL (c-LDL)más elevados (110,1 ± 31,4 frente a 102,9 ± 28,8 mg/dL; p &lt;0,043).Conclusión: Observamos una elevada prevalencia de ETA en pacientes conDM1, asociándose a sexo femenino, tabaquismo activo y niveles elevados dec-LDL. Recomendamos el cribado sistemático de ETA en pacientes con DM1,que permita un precoz diagnóstico y tratamiento(AU)</dc:description>
<dc:source>Av. diabetol;26(1): 42-46, ene.-feb. 2010. tab</dc:source>
<dc:identifier>ibc-83215</dc:identifier>
<dc:title xml:lang="es">Prevalencia de la enfermedad tiroidea autoinmune en pacientes con diabetes mellitus tipo 1</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d31048</dc:subject>
<dc:subject>^d19403^s22012</dc:subject>
<dc:subject>^d7117^s22080</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3944^s22080</dc:subject>
<dc:subject>^d23925^s22080</dc:subject>
<dc:subject>^d3944^s22012</dc:subject>
<dc:subject>^d25123</dc:subject>
<dc:subject>^d19403^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>201002</dc:date>
</metadata>
</record>
</ibecs-document>
